Searchable abstracts of presentations at key conferences in endocrinology

ea0065p31 | Adrenal and Cardiovascular | SFEBES2019

The PASS score is not a reliable measure of predicting aggressive potential in phaeochromocytoma – experience over 14 years at our University Teaching Hospital

Gohil Shailesh , Seehra Jaspreet , Chauhan Vishnusai , Richards Catherine , Lloyd David , Bhake Ragini , Bhardwaj Neil , Levy Miles

Background: The phaeochromocytoma of the adrenal gland scaled score (PASS) is used for histological reporting of phaeochromocytomas as a surrogate marker of malignant potential. A PASS score of ≥4 (of a maximum of 20) suggests an aggressive tumour and hence the importance of lifelong careful follow-up. However, the utility of the PASS score has been questioned recently due to the discordance between PASS score and clinical outcomes.Aim: To review t...